Statement of USP Zdrowie in connection with the emergence of the COVID-19 epidemiological threat
18 March 2020
, 2 min.

From the beginning of our existence, we have placed humans and their health at the center of our activities.

Guided by our mission: “We change the world around you – caring for the health of you and your loved ones,” as a leader in the over-the-counter products and medicines market in Poland, we feel particularly responsible for the health of our patients and employees. In connection with the emergence of the COVID-19 epidemic threat, we have implemented a series of preventive measures in our company aimed at further ensuring work safety and hygiene.

From March 16 until further notice, all employees of USP Zdrowie in Poland, excluding: production workers and other departments necessary to ensure continuity of production in Wrocław, as well as selected personnel of the pharmaceutical warehouse, are working remotely, staying at home.

Until further notice, we have also suspended visits of medical representatives in medical facilities (hospitals, clinics), pharmaceutical representatives in pharmacies, and sales representatives in stores.

The safety and availability of our products for our patients is our priority. Currently, our production is secure in terms of raw material availability. We continuously monitor the latest reports and information provided by organizations such as the World Health Organization, MZ, GIS, adhering to recommendations and making every effort to maintain the highest safety standards.